Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Quantum Biopharma Ltd (QNTM)

Quantum Biopharma Ltd (QNTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Quantum Biopharma Ltd 55 University Avenue Suite 1003 Toronto A6 M5J 2H7 CAN

www.quantumbiopharma.com Employees: 7 P: 416-854-8884

Sector:

Medical

Description:

Quantum BioPharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Quantum BioPharma, formerly known as FSD Pharma Inc., is based in Toronto, Ontario.

Key Statistics

Overview:

Market Capitalization, $K 33,159
Enterprise Value, $K 27,159
Shares Outstanding, K 3,816
Annual Sales, $ 0 K
Annual Net Income, $ -14,200 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,320 K
EBIT, $ -18,640 K
EBITDA, $ -18,150 K
60-Month Beta 0.15
% of Insider Shareholders 8.53%
% of Institutional Shareholders 1.24%
Float, K 3,490
% Float 91.47%
Short Interest 122
Short Float 3.20%
Short Volume Ratio 0.37

Growth:

1-Year Return 161.75%
3-Year Return -83.04%
5-Year Return -91.43%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 96.36%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.25 on 11/07/25
Next Earnings Date 03/27/26
Earnings Per Share ttm -8.78
EPS Growth vs. Prev Qtr 61.30%
EPS Growth vs. Prev Year 71.40%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-65 on 08/15/24

QNTM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -380.93%
Return-on-Assets % -152.04%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.43
Book Value/Share 1.97
Interest Coverage -496.33
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar